Discovery Park, a thriving high-quality science park playing a key role in the South East of England’s life sciences community, and MedCity, which supports and grows the world-leading life sciences ecosystem of the Greater South East of England, are pleased to announce that they are partnering on the high-profile Angels in Med City programme. Angels in MedCity brings potential investors together with life sciences experts and has helped over 25 healthcare/life sciences companies to raise over £20m in equity funding so far.
With a particular focus on diagnostics, digital health and medical device technologies, Angels in MedCity is delivered by MedCity and Newable Private Investing with further expertise from Angels4LifeSciences. Discovery Park will be supporting several workshops and pitching events over the next year.
Mayer Schreiber, CEO of Discovery Park, said, "Recognising the importance of access to finance as a driver of life sciences company growth, we are pleased to support the highly effective Angels in MedCity programme. Interaction between the life sciences community here at Discovery Park and Angels in MedCity is expected to be beneficial to both sides. We believe this is the start of a productive relationship with MedCity as it works to build the life sciences industry in South East England."
Sarah Haywood, CEO of MedCity, said, ‘Discovery Park is building a thriving life sciences tenant and investor community, and we look forward to working with it to help companies access the capital they need to grow. Angels in MedCity is proving itself to be a highly effective initiative and we thank Discovery Park for its support.’